In continuation for the search for newer molecules with minimal side effects, broad spectrum of activity and drug resistant pathogens, especially Mycobacterium tuberculosis a series of 2-(substituted)-N-(4oxo-2-(pyridine-2- yl)quinazolin-3(4H)-yl acetamide and 2 (substituted)-N-(4oxo-2-(pyridine-3-yl)quinazolin-3(4H)-yl acetamide were synthesized. The structure of the compounds has been confirmed by IR, NMR (1H & 13C), mass spectral data and elemental analysis. Antitubercular activity was performed by Microplate Alamar Blue Assay (MABA) method.
Select your language of interest to view the total content in your interested language
Der Pharma Chemica received 15261 citations as per Google Scholar report